Data as of Apr 17
| -0.04 / -0.73%|
The 9 analysts offering 12-month price forecasts for Idenix Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 9.00 and a low estimate of 3.00. The median estimate represents a -8.42% decrease from the last price of 5.46.
The current consensus among 9 polled investment analysts is to Hold stock in Idenix Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.